Company: CHNR
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001079973-25-000143
Chunk: 4

Company: CHINA NATURAL RESOURCES INC
Filing Date: 2025-01-27
Form: POS AM
Chunk 4
---
 based in and having operations in mainland China
could apply to a company’s operations in Hong Kong and Macau, if the laws applicable to mainland China become applicable to
entities and business in Hong Kong and Macau in the future. We currently do not have material operations in Hong Kong or Macau. It
is management’s understanding that there are no restrictions, limitations, rules, or regulations under Hong Kong law that are
commensurate to those of the PRC with respect to (i) payment of dividends and other distributions from the Company’s
subsidiaries to the Company, (ii) currency conversion that may affect payment of dividends or foreign currency denominated
obligations, (iii) offshore financing activities, (iv) anti-monopoly laws, or (v) data protection and cybersecurity, that have
impacted or may impact the Company’s ability to conduct its business, accept foreign investments, or list on a U.S. or other
exchange. For a detailed description of risks related to doing business in China, see “Risk Factors – Risks Relating to
Our PRC Operations and Doing Business in the PRC” in this prospectus. China Securities Regulatory Commission, or the
“CSRC”, promulgated the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies
(the “Trial Measures”), which became effective on March 31, 2023. The Company’s securities are currently publicly
listed on the Nasdaq Stock Market. Based on the opinion of our PRC legal counsel, solely for purpose of registration of up to
1,190,297 Common Shares issuable from the exercise of the Warrants for resale as described in this prospectus (the "Warrant
Shares Resale Registration"), we are not required to complete the CSRC filing procedures and obtain the CSRC approval under the
Trial Measures, because the Warrant Shares Resale Registration does not involve issuance of new securities of our Company in
addition to those previously included in our filing with the CSRC on February 26, 2024 for the issuance of the Warrants in
connection with the February 2024 Registered Offering. In case of subsequent exercises of the Warrants by holders of the Warrants,
where the issuances of the Common Shares upon such exercises are within the previously filed and authorized issuance limit, separate
filings for such exercises in the future are not required under the Trial Measures, and we shall only be required to provide a
summary report upon the completion of the remaining